Shared compound evidence record
Published analytical document
Ipamorelin (10mg) report
A crawlable context record for Janoshik task 99130. The stored public report image is embedded as served, and the SHA-256 value below fingerprints that repository asset.
Report transcription
- Laboratory
- Janoshik
- Task number
- 99130
- Sample label
- Ipa 10mg
- Batch shown
- IPA10D115P
- Tests requested (as printed)
- NAD+ analysis
- Testing ordered
- 14 January 2026
- Sample received
- 30 January 2026
- Analysis conducted
- 4 February 2026
- Stock relationship
- Not established
Results shown in the source
| Analyte | Measurement | Reported value(s) |
|---|---|---|
| Ipamorelin | content | 9.59 mg |
| Ipamorelin | purity | 99.820% |
The source's Tests requested field reads NAD+ analysis, while its sample and result labels identify Ipamorelin.
The tests-requested text printed on the image does not match its sample and result labels.
Stored public asset
Repository report image

SHA-256: BED00FBCE37F1302CEC8AB117068F01D6DED7A08B0A99CA365B84D9A5DF79F85
Verify with the laboratory using key NAZFUT75DU46 Connected catalogue records
Connected compound evidence
CJC-1295 (no DAC) (10mg)
Connected compound evidence
Tesamorelin (10mg)
Connected compound evidence
CJC-1295 with DAC (10mg)
Product recordDocumentation pending
Connected compound evidence
Tesamorelin (20mg)
Product recordDocumentation pending
Shared research topic